DUET: A Phase 2 Study Evaluating the Efficacy and Safety of Sparsentan in Patients with FSGS

DUET: A Phase 2 Study Evaluating the Efficacy and Safety of Sparsentan in Patients with FSGS is a paper indexed in ScholarIQ from OpenAlex.

How many citations does DUET: A Phase 2 Study Evaluating the Efficacy and Safety of Sparsentan in Patients with FSGS have?

DUET: A Phase 2 Study Evaluating the Efficacy and Safety of Sparsentan in Patients with FSGS has 185 citations in the OpenAlex counts ScholarIQ stores.

When was DUET: A Phase 2 Study Evaluating the Efficacy and Safety of Sparsentan in Patients with FSGS published?

DUET: A Phase 2 Study Evaluating the Efficacy and Safety of Sparsentan in Patients with FSGS has 2018 year in the ScholarIQ index.

What is the open-access status of DUET: A Phase 2 Study Evaluating the Efficacy and Safety of Sparsentan in Patients with FSGS?

DUET: A Phase 2 Study Evaluating the Efficacy and Safety of Sparsentan in Patients with FSGS has bronze oa status in the ScholarIQ index.

What is the DOI of DUET: A Phase 2 Study Evaluating the Efficacy and Safety of Sparsentan in Patients with FSGS?

The DOI for DUET: A Phase 2 Study Evaluating the Efficacy and Safety of Sparsentan in Patients with FSGS is on the source record.

What is the PMID of DUET: A Phase 2 Study Evaluating the Efficacy and Safety of Sparsentan in Patients with FSGS?

The PMID for DUET: A Phase 2 Study Evaluating the Efficacy and Safety of Sparsentan in Patients with FSGS is on the source record.

What is the OpenAlex record for DUET: A Phase 2 Study Evaluating the Efficacy and Safety of Sparsentan in Patients with FSGS?

The OpenAlex for DUET: A Phase 2 Study Evaluating the Efficacy and Safety of Sparsentan in Patients with FSGS is on the source record.